Complete Heart Block After Low Dose Octreotide Infusion for Esophageal Variceal Bleeding

Am Surg. 2023 Sep;89(9):3867-3869. doi: 10.1177/00031348231173937. Epub 2023 May 5.

Abstract

Cirrhosis and chronic liver disease cause a myriad of systemic health problems mostly caused by the presence of portal hypertension. Esophageal varices are one result of portal hypertension. They can rupture and bleed, which can be catastrophic in already coagulopathic liver failure patients. We present a patient who presented with decompensated liver failure for transplant. He developed a severe and refractory gastrointestinal bleed and was put on an octreotide infusion to increase splanchnic flow and decrease portal pressures. He subsequently developed complete heart block. Understanding the mechanisms of octreotide is imperative due to its frequent use in medically complex patients.

Keywords: Esophagus/foregut; GI bleed; Liver; Pharmacy; Transplant Surgery.

Publication types

  • Case Reports

MeSH terms

  • Esophageal and Gastric Varices* / complications
  • Esophageal and Gastric Varices* / drug therapy
  • Gastrointestinal Hemorrhage / complications
  • Gastrointestinal Hemorrhage / etiology
  • Heart Block / complications
  • Humans
  • Hypertension, Portal* / complications
  • Liver Cirrhosis / complications
  • Liver Failure*
  • Male
  • Octreotide / therapeutic use

Substances

  • Octreotide